Reference sequence (1): human-PGAP1
Identities normalised by aligned length.
Colored by: consensus/70% and property
 1 human-PGAP1    100.0%  IPVLFLPGNAGSYKQVRSIGSIA----------LRKAEDIDFKYHFDFFSVNFNEELVALYGGSLQKQTKFVHECIKTILKLYKGQEF-----------APKSVAIIGHSMGGLVARALL 
 2 ailme-d2hdi6    96.8%  IPVVFLPGNAGSYKQVRSVGSIA----------LRKAEDIDFRYHFDFFSVNFNEELVALYGGSLQKQTKFVHECIKTILKLYKGQEF-----------APKSVAIIGHSMGGLVARALL 
 3 bovin-e1bnq0    97.3%  IPVLFLPGNAGSYKQVRSIGSIA----------LRKAEDIDFKYHFDFFSVNFNEELVALYGGSLQKQTKFVHECIKTILKLYKGQEF-----------APKSVAIVGHSMGGLVARALL 
 4 canfa-e2r8v9    97.3%  IPVLFLPGNAGSYKQVRSLGSIA----------LRKAEDIDFKYHFDFFSVNFNEELVALYGGSLQKQTKFVHECIKTILKLYKGQEF-----------APKSVAIIGHSMGGLVARALL 
 5 mouse-q3uuq7    95.0%  IPVLFLPGNAGSYKQVRSIGSIA----------LRKAEDIDFKYHFDFFSVNFNEELVALYGGSLQKQTKFVHECIKAILKLYKGQEF-----------APTSVAIIGHSMGGLVARALL 
 6 ratno-q765a7    95.0%  IPVLFLPGNAGSYKQVRSIGSIA----------LRKAEDIDFKYHFDFFSVNFNEELVALYGGSLQKQTKFVHECIKAILKLYKGQEF-----------PPTSVAIIGHSMGGLVARALL 
 7 xenla-q66j01    74.5%  VPVLFLPGNAGSYKQARSFASVA----------LRKAENIGNRYHFNIFTVNFNEELVALYGGSLRRQTRFVHECIKTILSLYKNQTF-----------PPESVAIIGHSMGGLVARALF 
 8 ashgo-BST1      32.0%  IPVLFIPGNAGTYKQVRSIAAATANLYYGE---MRDALNNNNTKNLDFFTADFNEDFTAFHGRTMLDQAEYCNDAIRYILSIYELSDK----YRASGEPLPTSVLVVGHSMGGIVARVMT 
 9 klula-q6cin9    30.7%  IPVLFIPGNAGSFKQARSIAAASANLYFD----HKSTIQNSNAKNMDYFTADFNEDFTAFHGQTMLDQAVYLNDAVRYILSMYAQSAA----YKESNRPLPKSVILLGHSMGGIVARLML 
10 yeast-BST1      33.8%  IPVLFIPGNAGSFRQCRSIASACSNIYFDSN--TRATLRNENVRNLDFFTADFNEDFTAFHGETMLDQAEYLNDAIKYILSLYERTPD----Y---PHPKPQSVIIVGHSMGGIVSRVML 
11 debha-q6brg1    33.7%  IPILFIPGNAGSYRQVRSIAAETSDIYFDHY-LDQPDGLNPNAKNYDFFTADFNEDFTAFHGRTLLDQAEYLNEAIKFILGLYANSEH-----------PPRSVVVLGHSMGGVVSRVMV 
12 aspor-q2usi0    33.6%  VPVLFLPGNAGSYRQVRSLAAEASRHYYDVV-RHDEDRLNAGTRSLDFFMIDFNEDMAAFHGQTLLDQAEYVNEAVAYILSLYHDPRR---SRRDPELPDPSAVVLVGHSMGGIVARTAL 
13 asptn-bst1      34.4%  APVLFLPGNAGSYRQVRSLAAEASRHYFEVV-RHDQERLRSGTRSLDFFMIDFNEDMAAFHGQTLLDQAEYVNEAVAYILSLYHDPKR---SRRDPELPDPSSVIIIGHSMGGIVARTTL 
14 emeni-BST1      34.8%  APVLFLPGNAGSYRQVRSLAAEASRHYAQVV-QHDQERLRAGTRSLDFFMIDFNEDMAAFHGQTLLDQAEYVNEAVAYILSLYHDPRR---TRRDADLPDPSSVILIGHSMGGIVARTAL 
15 cocim-bst1      36.5%  VPVLFLPGNAGSYKQGRSLASEASLYFHDVL-QYHQERLKTGVRGLDFFMADFNEDMAAFHGQTLLDQAEYVNDALAYILSLYHDPRR---PGRDLNLPDPTSVILIGHSMGGIVARTVL 
16 phano-bst1      34.8%  APVLFIPGNAGSYKQVRSLAAESAYHYHNSV-QHESNAGKGERRPLDFFAVDFNEDFTAFHGQTVLDQAEYLNDAITFILSLYHTPGR---SRRDPHLPDPTSVIIVGHSMGGVVARTLF 
17 yarli-BST1B     35.0%  VPVIFVHGNAGGFRQIGPFAGIAQELNDE----LRLLTKGDAGTEFDFFSIDFNEAYSALHGRTLLDQAEYLNDAIAYILDMYKRNQQ-------EGLQVPESVIVLGHSMGGIVSRVAV 
18 yarli-q6cf60    33.3%  VPVLFVPGNAGSYRQIRSISDTCRELNEQ-----------YGGSEIDFFALDFNEAYSALHGRTLLDQAEYLNDAINYILQMYRDNGK-----------DVSSVMLLGHSMGGVVSRLAI 
19 schpo-BST1      32.8%  IPILFIPGNAGSYKQVRAFAAQAAHVYANAYAEDADGTLNAGKLVPDFFVVDFNEDFSAFHGQTLLDQAEYVNDAIPYILSLYRQNRKISSEYDNEAFPPPTSVILLGHSMGGIVAQATF 
20 anoga-q7psq5    34.5%  APVLFVPGSGGSYKQVRSLASVA----------LRKGLDNNWQAHLDYFSVDLNEELSGVYGGYLQDQTDFLDLCIQEITRLYGARGR------------TTRLFIVGHSVGGKLAQAVV 
21 drome-CG3160    35.5%  APVIFVPGNAGSYKQVRSLASVA----------LRKAMSNDAGIHLDYYTIDYDEELSALYGGYLHRQQSYLKLCIRTILSIYEGRTE------------QPSIVLIGHSMGGKLAQSVL 
22 caebr-a8y4l4    26.4%  IPVLFIPGSQGSAKQVRSIASVM----------QNKTEMRQSVFSFRFFAVDFDEEKTFMNGHTVNRQLDYVMKAIRKIQSLMRVKRR---------------IVLIGHSYGGMVALLTT 
23 caeel-T19B10.8  26.2%  IPVLFIPGSQGSGKQIRSLASVM----------QNKTEMRYAPFSFRFFAVDFDEEMTFMNGHIVKRQIEYVMKAIRKIQSMMRGNRK---------------IVLVGHSYGGMIALLTT 
   consensus/100%         hPllFl.GstGsh+Qhtshus.........................pha.hshsEthshh.Gt.h.cQ..ah..sl..I.thht...................lhllGHShGGhlu..hh 
   consensus/90%          hPVlFlPGsuGSa+QhRShuu.s...........p.t.....hhthcaF.hsFsE-hsuhaGt.h.cQtcalpcslthIhphYtt.t...............tlhllGHShGGhluphhh 
   consensus/80%          hPVLFlPGNAGSa+QlRSluu.s...........ppt...s.thphDFFshsFNE-hsAhaGtol.cQscalp-slthILplYct.th............spSVhllGHSMGGlVApshh 
   consensus/70%          lPVLFlPGNAGSY+QlRSluu.u..........hcpst..s.thphDFFslsFNE-hsAhaGtoL.cQscalp-sIphILpLY+spph............PpSVhllGHSMGGlVARshl 

 1 human-PGAP1    100.0%  TLKNFKHDLINLLITQATPHVAPVMPLDRFITDFYTTVNNYW---ILNA----------------------------RHI-NLTTLSVAGGFRDYQVRSGLTFLPKLSHHTSA----LSV 
 2 ailme-d2hdi6    96.8%  TLKNFKQDLINLLITQATPHVAPVMPLDRFITDFYMTVNNYW---ILNA----------------------------RHI-NLTTLSVAGGFRDYQVRSGLTFLPKLSHHTSA----LSV 
 3 bovin-e1bnq0    97.3%  TLKNFKQDLINLLVTQATPHVAPVMPLDRFITDFYMTVNNYW---ILNA----------------------------RQI-NLTTLSVAGGFRDYQVRSGLTFLPKLSHHTSA----LSV 
 4 canfa-e2r8v9    97.3%  TLKNFKQDLINLLITQATPHVAPVMPLDRFITDFYVTVNNYW---ILNA----------------------------RHI-NFTTLSVAGGFRDYQVRSGLTFLPKLSHHTSA----LSV 
 5 mouse-q3uuq7    95.0%  TLKNFKQDLINLLVTQATPHVAPVMPLDRFITEFYMNVDNYW---ILNA----------------------------RHI-NLTTLSVAGGFRDYQVRSGLTFLPKLSHYTSA----LSV 
 6 ratno-q765a7    95.0%  TLKNFKQDLINLLVTQATPHVAPVMPLDRFITEFYMTVNNYW---ILNA----------------------------RHI-NLTTLSVAGGFRDYQVRSGLTFLPTLSHHTSA----LSV 
 7 xenla-q66j01    74.5%  TLKHFKPDLINVIITQATPHILPVLSTDIYLTDFYTMVNNYW---IYNS----------------------------LKLRNITMLSVAGGYSDYQVRSGLTFLPTSSFHTSA----LSV 
 8 ashgo-BST1      32.0%  TLKNHIPQSINTILTLSSPHSTAPATFDGDILKIYNAMNAFW---ESKFRDRDKDP---------------------FYAENVSVISITGGVLDSVLPADYTSLEGIIPSDNG----FTT 
 9 klula-q6cin9    30.7%  TLPNHIPESVNTILTLSSPHSTAPVTFDGDILKLYDRVNSYW---TSAMNDMGS-----------------------YFRNNVSVISITGGILDDILPADYTNLQGIVPESNG----FTT 
10 yeast-BST1      33.8%  TLKNHVPGSISTILTLSSPHAASPVTFDGDILKLYKNTNEYW---RKQLSQNDS-----------------------FFSKNISLVSITGGILDTTLPADYASVEDLVSLENG----FTS 
11 debha-q6brg1    33.7%  SLPNYIPDSINTIITLASPHAAAPLTFDGDILKIYSAVDRFW---FQGYDNKETDNTIAKIAK--------------ERLSKISLISITGGLLDSILPADYTTLGYLVPPTNG----FTV 
12 aspor-q2usi0    33.6%  TMTNYQANSVNTIVTMSAPHAKPPVSFDSDIVQTYKQINDYW---REAYSQTWAND---------------------NPLWHVTLISIAGGSRDTVVPSDYASISSLVPETHG----FTV 
13 asptn-bst1      34.4%  TMSNYQANSVNTIITMSAPHAKPPVSFESDVVHTYKQINDYW---REAYSQTWANN---------------------NPLWHVTLISIAGGSRDTVVPSDYASISSLVPETHG----FTV 
14 emeni-BST1      34.8%  TMANYQENSVNTIITMSAPHAKAPVSFDSDIVHTYKQINDYW---REAYSQTWANN---------------------NPLWHVTLISIAGGSRDTVVPSDYASISSLVPETHG----FTV 
15 cocim-bst1      36.5%  TMSNYQTNSVNTIITMSTPHARPPVSFDSDLVHTYKQVNNYW---REAYSQKWANN---------------------NPLWHVTLISIAGGGGDTIVPSDYTSLSSLVPETHG----FTV 
16 phano-bst1      34.8%  TMPNYQANSINTIVTIAAPHARPPVSFDGDIVRTQNAVNSYW---RSAYAQDSAKD---------------------NPLQHVTLVSIAGGGLDNIVSSDYASIASIVPETHG----FTV 
17 yarli-BST1B     35.0%  TLENYRPQSVNTIITLASPHLIPAATFDADITKVYHLVNDYW---RAAFAEGDTND---------------------NPLRDITILSIAGGKSDTMVPSDYVSLDSLVPATNG----LST 
18 yarli-q6cf60    33.3%  SLDNYKPGTVTTIFTLASPHLVPPATFDGDIQKVYNRMNDFW---RSNYAD--SDN---------------------NSLSDMTVLSIAGGKRDTMVPSDYISLDSVVPSSHG----LST 
19 schpo-BST1      32.8%  TMKNYVDGSVNTLITLATPHAMAPLPFDRHLVEFYESIKNFW---SQSFLLS-PEE---------------------NSLDDVLLVSIAGGGLDTHVVPEYSSISTFVPPSNG----LMV 
20 anoga-q7psq5    34.5%  GARTSIGRHVAGIVTLSAPVDKPVALFDHYHYSFYDRIEQAW---RTNRSLAGAANASPSHGL--------------LPLDGILFVTIGGGIRDIIVHDGLTA-----SRYAD----LHA 
21 drome-CG3160    35.5%  -VDPAIGQHINTIISISTPLDQPVLNLDTQLEEFYDQTDAVLSKLRTATVPTMTTNVCDSLHQRPPSVQRMASQDSSARLDNVLLISTGGGNRDLLVRPGLTS-----SRFND----LHA 
22 caebr-a8y4l4    26.4%  VHPDFH-DDIELVIVKGAPITKTPILNDWTTLRLNKLLTTKW---D------LLQA---------------------SDLKHVGVVAYTGGLRDFQIPDEWSIMRN-------------- 
23 caeel-T19B10.8  26.2%  IYPEYQ-KDVELIIVKGAPLNKQPLVNDWFSLRFNLLLVNQW---N------ALQN---------------------NNLSHVGVVAYSGGIRDYMIPDEWSILRNVRAVIMKVTIKFSA 
   consensus/100%         .h.....t.lthlhs.usPh...sh..-....ph...h.t.h.......................................th.hlshsGG..D..l.sth................... 
   consensus/90%          sh.sa..t.lshllo.usPh.hsshshD..hhch...hsphW.....t...............................h.pl.hlohsGG.hD..l.sths.h.......ts....hps 
   consensus/80%          oh.sa..p.lshllT.usPHstsshshDt.lhchY.tlssaW...h.sh..............................l.plshlSlsGGhhDh.l.sshs.l.th...ppu....hos 
   consensus/70%          ThpNah.s.lNhllT.usPHstsshshDt.lhchYptlssaW...h.sh............................p.l.plohlSluGGhtDh.V.ushs.l.pls.topu....hos 

 1 human-PGAP1    100.0%  VSSAVPKTW-------VSTDHLSIVWCKQLQLTTVRAFFDLIG 
 2 ailme-d2hdi6    96.8%  VSSAVPKTW-------VSTDHLSIVWCKQLQLTTIRAFFDLID 
 3 bovin-e1bnq0    97.3%  VSSAVPKTW-------VSTDHLSIVWCKQLQLTTVRAFFDLID 
 4 canfa-e2r8v9    97.3%  VSSAVPKTW-------VSTDHLSIVWCKQLQLTTIRAFFDLID 
 5 mouse-q3uuq7    95.0%  VSSAVPKTW-------VSTDHLSIVWCKQLQLTTIRAFFDLID 
 6 ratno-q765a7    95.0%  VTSAVPKTW-------VSTDHLSIVWCKQLQLTTIRAFFDLID 
 7 xenla-q66j01    74.5%  VSSAVPITW-------ASTDHLSIVWCRELVLVTARALFDLID 
 8 ashgo-BST1      32.0%  YTTTIPWVW-------TPIDHLAIVWCDQLRIVVAKLLLELVD 
 9 klula-q6cin9    30.7%  FTTTIPELW-------TPIDHLAIVWCDQLRYLLAKYILEIVN 
10 yeast-BST1      33.8%  FTTTIPDVW-------TPIDHLAIVWCKQLREVLARLLLE--- 
11 debha-q6brg1    33.7%  YTTGIPGVW-------TPIDHLAIVWCAQLRRRVLNALLEIAN 
12 aspor-q2usi0    33.6%  FTSTIPDVW-------IGMDHLSITWCDQFRKAIIKSLFEVVD 
13 asptn-bst1      34.4%  FTSTIPDVW-------IGMDHLSITWCDQFRKAIIKSLFEIVD 
14 emeni-BST1      34.8%  FTSTMPDVW-------IGVDHLSITWCDQFRKAIIKSLFDVVD 
15 cocim-bst1      36.5%  FTTTIPNVW-------TGMDHLSIAWCDSFRKVIIRSLFDVID 
16 phano-bst1      34.8%  FSSSIPNCW-------TGADHLAITWCDQVRKSIVRALYDVVD 
17 yarli-BST1B     35.0%  FTNSIARVW-------TGIDHDAVMWCHQLRRQIASALFHIVD 
18 yarli-q6cf60    33.3%  FSNSINRVW-------TGIDHDAMMWCHQLRRQIAIALMNVID 
19 schpo-BST1      32.8%  FTSGIPSVW-------AEIDHQAMAWCENFRRVLIRGIFAIMD 
20 anoga-q7psq5    34.5%  MTHNIPNVW-------LSVDHLCAMWCLQFVLVMNRFLFSM-- 
21 drome-CG3160    35.5%  MTSAIPKVS-------LSCDHLSAVWCLQFMQAINRFLFSVAY 
22 caebr-a8y4l4    26.4%  -VTHRP-IWAVGGVSDLGADHLAILWCNEFVRHVSRVLYFYGE 
23 caeel-T19B10.8  26.2%  QVTNRP-LWAIDGVSDLGADHLAILWCNE-------------- 
   consensus/100%         .spths.h........h.hDH.shhWC.p.............. 
   consensus/90%          hosshP.hW.......hshDH.uhhWCtph...h.p.hhth.. 
   consensus/80%          hooslPtsW.......hshDHLulhWCpph.hhhh+.hhplht 
   consensus/70%          hooslPpsW.......huhDHLuIsWCcQhphshh+shaclhs 

MView 1.56, Copyright © 1997-2013 Nigel P. Brown